Ion Beam Applications SA's latest sales figures may change the minds of naysayers who doubt whether proton therapy for cancer would really take off because it is too expensive for widespread clinical use.
The Belgian company reported a 41% jump in proton therapy sales for the first six months of 2016, at €96.6m....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?